Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Hooper

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Drugs|December 20, 1999
Mode of action of fluoroquinolonesD C Hooper
Emerging Infectious Diseases|April 11, 2001
Emerging mechanisms of fluoroquinolone resistanceD C Hooper
Drugs|January 1, 1993
Quinolone mode of action--new aspectsD C Hooper
Advances in Experimental Medicine and Biology|January 1, 1995
Bacterial resistance to fluoroquinolones: mechanisms and patternsD C Hooper
Immunology Today|October 8, 2014
Self-tolerance for erythrocytes is not maintained by clonal deletion of T helper cellsD C Hooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Mechanisms of action of antimicrobials: focus on fluoroquinolonesD C Hooper
Antimicrobial Agents and Chemotherapy|August 4, 1998
Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activityB Fournier, D C Hooper
Vaccine|August 26, 1998
Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV)B Dietzschold, D C Hooper
Antimicrobial Agents and Chemotherapy|September 15, 2001
Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureusD Ince, D C Hooper
Antimicrobial Agents and Chemotherapy|November 18, 2000
Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactionsD Ince, D C Hooper
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Drugs|December 20, 1999
Mode of action of fluoroquinolonesD C Hooper
Emerging Infectious Diseases|April 11, 2001
Emerging mechanisms of fluoroquinolone resistanceD C Hooper
Drugs|January 1, 1993
Quinolone mode of action--new aspectsD C Hooper
Advances in Experimental Medicine and Biology|January 1, 1995
Bacterial resistance to fluoroquinolones: mechanisms and patternsD C Hooper
Immunology Today|October 8, 2014
Self-tolerance for erythrocytes is not maintained by clonal deletion of T helper cellsD C Hooper
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Mechanisms of action of antimicrobials: focus on fluoroquinolonesD C Hooper
Antimicrobial Agents and Chemotherapy|August 4, 1998
Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activityB Fournier, D C Hooper
Vaccine|August 26, 1998
Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV)B Dietzschold, D C Hooper
Antimicrobial Agents and Chemotherapy|September 15, 2001
Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureusD Ince, D C Hooper
Antimicrobial Agents and Chemotherapy|November 18, 2000
Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: novel mutations suggest novel drug-target interactionsD Ince, D C Hooper
Pageof 18